Beihai Gofar Chuanshan Biological Co., Ltd. (SHA:600538)
6.72
-0.13 (-1.90%)
Apr 30, 2026, 3:00 PM CST
SHA:600538 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 150.77 | 144.84 | 155.26 | 170.86 | 190.4 |
Cash & Short-Term Investments | 150.77 | 144.84 | 155.26 | 170.86 | 190.4 |
Cash Growth | 4.09% | -6.71% | -9.13% | -10.27% | -16.31% |
Accounts Receivable | 254.11 | 254.08 | 270.94 | 272.02 | 210.43 |
Other Receivables | 2.34 | 2.15 | 3.71 | 2.71 | 9.24 |
Receivables | 256.45 | 256.23 | 274.65 | 274.74 | 219.67 |
Inventory | 89.6 | 82.94 | 80 | 84.92 | 73.19 |
Prepaid Expenses | 1.24 | 1.04 | 1.08 | 1.94 | 0.01 |
Other Current Assets | 6.62 | 6.32 | 8.13 | 10.8 | 25.56 |
Total Current Assets | 504.67 | 491.36 | 519.12 | 543.26 | 508.82 |
Property, Plant & Equipment | 134.69 | 148.34 | 118.25 | 119.11 | 117.62 |
Long-Term Investments | 104.51 | 108.65 | 134.06 | 141.42 | 107.31 |
Goodwill | 76.6 | 138.46 | 198.67 | 254.1 | 254.1 |
Other Intangible Assets | 25.95 | 27.29 | 27.78 | 28.91 | 30.22 |
Long-Term Accounts Receivable | 1.52 | 4.98 | 9.72 | 2.52 | 2.88 |
Long-Term Deferred Tax Assets | 6.87 | 5.62 | 4.15 | 3.96 | 3.33 |
Long-Term Deferred Charges | 5.86 | 5.12 | 6.18 | 6.05 | 7.31 |
Other Long-Term Assets | 36.15 | 36.93 | 37.6 | 42.84 | 51.19 |
Total Assets | 896.82 | 966.75 | 1,056 | 1,142 | 1,083 |
Accounts Payable | 74.34 | 72.39 | 74.01 | 67.27 | 59.92 |
Accrued Expenses | 14.3 | 14.89 | 15.47 | 22.04 | 12.09 |
Short-Term Debt | - | 0.95 | 7.34 | 10 | 1 |
Current Portion of Leases | 4.83 | 5.22 | 2.96 | 1.67 | 2.89 |
Current Income Taxes Payable | 1.43 | 0.58 | 1.13 | 1.39 | 2.14 |
Current Unearned Revenue | 18.6 | 18.68 | 20.89 | 38.29 | 37.58 |
Other Current Liabilities | 29.42 | 29.23 | 46.76 | 37.63 | 41.72 |
Total Current Liabilities | 142.92 | 141.95 | 168.57 | 178.29 | 157.34 |
Long-Term Debt | 20.02 | - | - | - | - |
Long-Term Leases | 31.05 | 35.43 | 5.51 | 2.85 | 2.57 |
Long-Term Deferred Tax Liabilities | 2.04 | 1.98 | 2.14 | 1.05 | 0.26 |
Total Liabilities | 196.03 | 179.36 | 176.22 | 182.2 | 160.16 |
Common Stock | 524.2 | 524.2 | 524.2 | 524.2 | 524.2 |
Additional Paid-In Capital | 784.89 | 784.88 | 784.88 | 784.88 | 784.88 |
Retained Earnings | -620.21 | -532.59 | -438.74 | -356.43 | -391.28 |
Comprehensive Income & Other | -1.1 | -1.1 | -1.1 | -1.1 | -1.1 |
Total Common Equity | 687.78 | 775.39 | 869.24 | 951.55 | 916.7 |
Minority Interest | 13 | 12 | 10.07 | 8.42 | 5.91 |
Shareholders' Equity | 700.78 | 787.39 | 879.3 | 959.96 | 922.61 |
Total Liabilities & Equity | 896.82 | 966.75 | 1,056 | 1,142 | 1,083 |
Total Debt | 55.9 | 41.6 | 15.81 | 14.52 | 6.46 |
Net Cash (Debt) | 94.87 | 103.24 | 139.45 | 156.34 | 183.95 |
Net Cash Growth | -8.11% | -25.97% | -10.80% | -15.01% | -19.14% |
Net Cash Per Share | 0.18 | 0.20 | 0.27 | 0.31 | 0.35 |
Filing Date Shares Outstanding | 524.2 | 524.2 | 524.2 | 524.2 | 524.2 |
Total Common Shares Outstanding | 524.2 | 524.2 | 524.2 | 524.2 | 524.2 |
Working Capital | 361.74 | 349.41 | 350.55 | 364.97 | 351.49 |
Book Value Per Share | 1.31 | 1.48 | 1.66 | 1.82 | 1.75 |
Tangible Book Value | 585.23 | 609.64 | 642.79 | 668.54 | 632.39 |
Tangible Book Value Per Share | 1.12 | 1.16 | 1.23 | 1.28 | 1.21 |
Buildings | 131.26 | 131.26 | 130.11 | 129.91 | 120.3 |
Machinery | 134.57 | 138.09 | 133.43 | 131.06 | 126.39 |
Construction In Progress | 2.16 | 1.96 | 4.82 | - | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.